Literature DB >> 7535527

Molecular cloning and characterization of mouse HS1.

D Kitamura1, H Kaneko, I Taniuchi, K Akagi, K Yamamura, T Watanabe.   

Abstract

Here we report the cloning of a cDNA and a genomic DNA encoding the mouse homolog of human HS1, a hematopoietic cell-specific protein-substrate of non-receptor type protein-tyrosine kinase(s). Sequence analysis of the mouse HS1 cDNA revealed that it is highly homologous to human HS1 (total percent match = 84%) especially in the amino-terminal half, which contains unique repeating motifs, and in the carboxyl-terminal Src-homology 3 domain. As is the human counterpart, the mouse HS1 gene is expressed exclusively in hematopoietic cells. Genomic fragments covering most of the HS1 gene were isolated and used to map this gene to mouse chromosome 16.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535527     DOI: 10.1006/bbrc.1995.1452

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.

Authors:  Y Kawaguchi; K Nakajima; M Igarashi; T Morita; M Tanaka; M Suzuki; A Yokoyama; G Matsuda; K Kato; M Kanamori; K Hirai
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Authors:  Wenting Liu; Hiroaki Kajiyama; Kiyosumi Shibata; Yoshihiro Koya; Takeshi Senga; Fumitaka Kikkawa
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

3.  Cortactin has an essential and specific role in osteoclast actin assembly.

Authors:  Shandiz Tehrani; Roberta Faccio; Indra Chandrasekar; F Patrick Ross; John A Cooper
Journal:  Mol Biol Cell       Date:  2006-04-12       Impact factor: 4.138

4.  Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons.

Authors:  Y Du; S A Weed; W C Xiong; T D Marshall; J T Parsons
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

5.  Identification of RNA-binding Proteins in Macrophages by Interactome Capture.

Authors:  Anke Liepelt; Isabel S Naarmann-de Vries; Nadine Simons; Katrin Eichelbaum; Sophia Föhr; Stuart K Archer; Alfredo Castello; Björn Usadel; Jeroen Krijgsveld; Thomas Preiss; Gernot Marx; Matthias W Hentze; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  Mol Cell Proteomics       Date:  2016-06-08       Impact factor: 5.911

6.  Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.

Authors:  Cristina Gattazzo; Veronica Martini; Federica Frezzato; Valentina Trimarco; Elena Tibaldi; Monica Castelli; Monica Facco; Francesca Zonta; Anna Maria Brunati; Renato Zambello; Gianpietro Semenzato; Livio Trentin
Journal:  Haematologica       Date:  2014-02-14       Impact factor: 9.941

7.  Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases.

Authors:  I Taniuchi; D Kitamura; Y Maekawa; T Fukuda; H Kishi; T Watanabe
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

8.  Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis.

Authors:  Y Yamanashi; T Fukuda; H Nishizumi; T Inazu; K Higashi; D Kitamura; T Ishida; H Yamamura; T Watanabe; T Yamamoto
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

9.  Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.

Authors:  Agnes G S H van Rossum; Ellen Schuuring-Scholtes; Vera van Buuren-van Seggelen; Philip M Kluin; Ed Schuuring
Journal:  BMC Genomics       Date:  2005-02-14       Impact factor: 3.969

10.  The actin binding proteins cortactin and HS1 are dispensable for platelet actin nodule and megakaryocyte podosome formation.

Authors:  Steven G Thomas; Natalie S Poulter; Danai Bem; Brenda Finney; Laura M Machesky; Stephen P Watson
Journal:  Platelets       Date:  2016-10-25       Impact factor: 3.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.